Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julie Garon-Czmil"'
Publikováno v:
Therapies. 76:510-512
Autor:
Julie Garon-Czmil, Camille Rasmussen, Joe-Elie Salem, Loïc Guillevin, Benjamin Terrier, Laurent Chouchana, Mylène Tisseyre, Marina Atzenhoffer, Jean-Marc Treluyer
Publikováno v:
Autoimmunity Reviews
Autoimmunity Reviews, Elsevier, 2021, 20 (1), pp.102707. ⟨10.1016/j.autrev.2020.102707⟩
Autoimmunity Reviews, Elsevier, 2021, 20 (1), pp.102707. ⟨10.1016/j.autrev.2020.102707⟩
Objectives IgA vasculitis (IgAV) is an immune complex small-vessel vasculitis. Drug-induced IgAV cases were rarely reported in the literature. Drug causality assessment is challenging as many other etiological factors can be involved. We performed a
Autor:
Nadine Petitpain, Julie Garon-Czmil, Franck Rouby, Marion Sassier, Georges Weryha, Marc Klein, Pierre Gillet, Samy Babai, Melissa Yelehe-Okouma
Publikováno v:
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Fundamental & Clinical Pharmacology, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Immunotherapy with immune checkpoint inhibitors (ICIs) for cancer has become increasingly prescribed in recent years. Indeed, it is used to treat both solid and hematological malignancies due to their considerable potential in treating melanoma, non-